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Abstract 
Background: People with epilepsy are at increased risk of accidents and injuries but despite 
several studies on this subject, data regarding preventable causes are still contradictory. The 
aim of this study is to investigate the relationship between injuries, side effects of antiepileptic 
drugs (AED) and depression.   
Methods: Data from a consecutive sample of adult patients with epilepsy attending the 
Outpatient Clinics at St George’s University Hospital in London were included. All patients 
were asked if they had any injury since last clinic appointment and completed the Liverpool 
Adverse Event Profile (LAEP) and the Neurological Disorders Depression Inventory 
for Epilepsy (NDDI-E).  
Results: Among 407 patients, 243 females, mean age 43.1 years, 71 (17.4%) reported injuries 
since last appointment. A two-step cluster analysis revealed two clusters with the major one 
(53.5% of the injured group) showing a total score for LAEP ≥45, a positive NDDI-E 
screening and presence of AED polytherapy. A total score for LAEP ≥45 was the most 
important predictor. 
Conclusion: AED treatment should be reviewed in patients reporting injuries in order to 
evaluate the potential contribution and burden of AED side effects.  
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BACKGROUND 
People with epilepsy are at increased risk of injury when compared to the general 
population [1]. This is obviously associated with increased costs and poor quality of life. 
Previous studies attempted to identify implicated variables to develop prevention strategies. In 
adult patients, multivariate analyses show that seizure severity, type and frequency are the 
best predictors of all types of injuries  [2,3] but seizure frequency and number of drug-related 
side effects have been associated with injuries as well [4,5]. In children with epilepsy, 
attention-deficit/hyperactivity disorder [6,7] and intellectual disabilities [8] were found to be 
implicated while epilepsy duration, gender and age were never found to be associated [9]. 
 
Although, ideally, a better seizure control represents the best way to reduce the likelihood for 
accidents and injuries, this cannot be always achieved as one third of patients present with 
drug-refractory epilepsy. It is, therefore, important to explore other possible modifiable 
factors increasing the risk of injuries in patients with epilepsy. Mood disorders represent the 
most frequently encountered psychiatric comorbidities in patients with epilepsy. These are 
associated with poor quality of life (QoL), seizure severity, side effects of anti-epileptic drugs, 
drug-resistance and a poor outcome after epilepsy surgery [10-12]. However, it is unknown 
whether psychiatric comorbidities represent an additional risk factor for injuries.  
The aim of the present paper is to look at the relationship between injuries, side effects of 
AEDs and depression.  
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MATERIALS AND METHODS  
 Data from a consecutive sample of patients with an established diagnosis of epilepsy 
attending the epilepsy outpatient clinics at the Atkinson Morley Regional Neurosciences 
Centre, St George’s University Hospitals NHS Foundation Trust in London, were analysed. 
As part of our routine clinical activity, all patients filled a self-administered questionnaire. 
This comprised of a question whether they suffered any injuries since their last appointment 
(usually six months), the Neurological Disorders Depression Inventory for Epilepsy (NDDI-
E) and the Liverpool Adverse Event Profile (LAEP). 
The NDDI-E is a well-known clinical instrument, developed for the rapid and objective 
detection of a major depressive episode in patients with epilepsy using a cut off score >15. It 
is accepted as a practical and user-friendly screening instrument in an outpatient setting. The 
LAEP is a 19-item, self-report instrument specifically developed to investigate side effects of 
AEDs. It is possible to analyse the scores of individual symptoms as well as calculate overall 
symptom score. Each symptom is quantified on a four-point Likert scale, with 1 indicating 
that there was “never” a problem; 2 “rarely” a problem; 3 “sometimes” a problem; 4 “always” 
problem.  
As per Research Ethic Committee (REC) advice, research limited to secondary use of 
anonymized information previously collected in the course of normal care is excluded from 
formal REC review. Data storage and management was compliant with the Good Clinical 
Practice statement in accordance to the Declaration of Helsinki. 
 
Data analysis and statistical methods 
The following variables were included: age, gender, ethnicity (Caucasian, African, Asian, 
mixed, others), duration of the epilepsy, drug treatment for epilepsy, LAEP score which was 
dichotomised as <44 and ≥45 (a LEAP score of ≥45 is considered an unacceptable burden 
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[13]), presence of seizures in the last 6 months dichotomised as present or not present, 
presence of depression according to NDDI-E, using more than one AED was coded as 
polytherapy. LAEP items were also included individually in the analysis.  
Initially, patients with and without injuries were compared for clinical and demographic 
variables. The Chi-square and Fisher’s exact tests were used to analyse qualitative variables. 
Mann–Whitney U test was applied to compare quantitative variables between two groups. 
Individual LAEP items were also compared in the two groups adopting an alpha error 
corrected for multiple comparisons (0.05/19 = 0.0026). 
Subsequently, a two-step cluster analysis with the previously identified variables was 
conducted in the group of patients with injuries to identify specific subgroups. Cluster 
analysis is an exploratory data analysis tool aimed at sorting different objects into groups in a 
way that the degree of association between two objects is maximal. Cluster groups were 
determined automatically by SPSS on basis of the best fit. Model fit indicated by the average 
silhouette of cohesion and separation was 0.5, which is considered as good [14]. 
All statistical analyses were performed using SPSS version 22.0 for Windows.  
 
RESULTS 
Data from 407 patients (243 female) were analysed. The mean age was 43.09 years +/- 
15.75. Three hundred twenty-five patients were Caucasian, 35 were African, 33 were Asian, 8 
were mixed and 6 were from other nationalities. Seventy-one patients (17.4%) had at least one 
injury since last appointment (injury (+) group). The remaining 336 patients (82.5%) did not 
suffer any injuries since last appointment (injury (-) group). Tables 1 and 2 summarise the 
data of both groups. 
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When both groups were compared in the descriptive analysis, the injury (+) group included 
more patients having seizures (p<0.001), using multiple anti-epileptic drugs (p=0.01), having 
a higher LAEP score (p<0.001), having depression according to the NDDI-E screening 
(p=0.002), having the side effects of restlessness (p=0.002), upset stomach (p<0.001), 
difficulty in concentration (p<0.001), trouble with gums (p<0.001), dizziness (p<0.001), 
depression (p=0.01), memory problems (p=0.01), and disturbed sleep (p<0.001) (tables 1 and 
2).  
A two-step cluster analysis including all associated variables showed that a high LAEP score 
(>45) identified two groups of patients: 53.5% of the injury (+) group with a high adverse 
event total score and the remaining 46.5% with no side effects (Table-3). 
 
DISCUSSION 
 In this study, we identify further risk factors associated with injury in people with epilepsy. 
In our sample, 17.4% epilepsy out-patients reported an injury since their last review (typically 
6 months). This is higher than rates reported in other studies. Epidemiological studies report a 
relative risk of 2.9 for injuries in patients with generalised tonic-clonic seizures [15] and a 5% 
chance per year of visiting an emergency department with a seizure-related injury [16]. 
However, other injuries such as mechanical falls were not reported. The Rest-1 study [2], 
found only 24% of injuries seizure related. In the remaining 76% other precipitants may have 
been present. Little is known about the potential role of AEDs side effects.  
As compared to the injury (-) group, patients with injury since last appointment were more 
likely to have a higher LAEP score (≥45), to be on a polytherapy, to have suffered seizures in 
the last 6 months and a positive screening for depression. Looking at the individual LAEP 
items in the two populations, patients with injuries are more likely to have high scores for 
global cognitive slowing (i.e.  memory problems, difficulties in concentrating), coordination 
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problems (i.e. dizziness) and sleep problems (i.e. disturbed sleep and upset stomach). 
Interestingly enough, they also reported more problems with gums as compared with injury  
(-) patients potentially suggesting a high proportion of patients on phenytoin. However, in our 
dataset the most frequently used anti-epileptic drug was Levetiracetam (42.3%) followed by 
Lamotrigine (28.2%), Valproate (23.9%), Carbamazepine (23.9%), Pregabalin (7%) and 
Topiramate (5.6%). 
Another interesting finding comes from the cluster analysis in the group of patients with 
injury that revealed two cluster groups. Both groups are characterised by a similar pattern of 
concomitant factors like the presence of uncontrolled seizure, polytherapy and depression. 
However, the difference is a total LAEP score of more than 45. In fact, in 53.5% of patients, a 
LAEP≥45 represents the most important predictor having the highest importance 
(importance=1), suggesting that these patients present a significant burden of side effects 
(more than 45 is usually considered an unacceptable burden). It is possible to speculate that 
these accidents might be due to drug toxicity causing both, side effects and injuries. In the 
other group, the total burden of side effects does not seem to be relevant and other factors, 
still unidentified, play a role. It seems evident that further studies on this subject are needed. 
 The association between depression and injuries is another interesting finding of our study. 
Depression represents one of most commonly reported psychiatric comorbidities of epilepsy 
[17] being reported in up to one third of patients [18]. Patients with psychiatric comorbidities 
are also more likely to be drug refractory [19] and it is possible that the association with 
injuries reflects just the increased chances of having uncontrolled seizures. However, 
epidemiological studies showed that patients with epilepsy have three times increased 
suicidality risk as compared to the general population with even higher rates in patients with 
epilepsy and depression [19-22]. It is reported that patients with epilepsy have higher 
incidences of home, street and work accidents, even without seizures [2]. One explanation 
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proposed is the reduced attentional processes and information-processing speed with frequent 
interictal EEG epileptiform discharges occurring in the absence of obvious clinical seizure 
activity [23, 24]. Those deficits may contribute to injury mechanism. However, these may be 
due to psychomotor slowing due to AEDs or even due to depression itself.  
 
Our results should be considered bearing in mind the following limitations. First, the seizure 
type was not recorded. Second, causes of the injuries were not recorded and it was not 
possible to distinguish between “seizure-related” and “seizure-unrelated” injuries. Third, the 
type of injury was not recorded. Fourth, presence of injury since last appointment without a 
specific date, whereas NDDI-E and LAEP refer to the last two weeks prior to the 
appointment. Hence, we can’t differentiate if higher LAEP scores occur as a result or cause of 
injury. Additionally, retrospective self-reporting via questionnaires bares some limitations. 
Recall of injuries seems to be reliable but when more detailed information is requested the 
level of recall accuracy might decline [25]. The effect of adoption of a single question for 
injuries compared to a structured questionnaire may have influence on recall bias as well. 
  
CONCLUSION 
In conclusion, we suggest that individuals presenting with injuries should be evaluated for the 
side effect burden of anti-epileptic drugs and precautions should be taken. To avoid further 
injury, focusing on side effects of anti-epileptic drugs, following up their essential minimum 
dosages and blood levels, deciding the suitable earliest time for discontinuing or change of 
AED, and being aware of drug-drug interactions would be substantial. Further prospective 
studies with more detailed and ideally prospectively recorded injury via a structured 
questionnaire are needed to ascertain which type of drug choice and interactions mostly cause 
injuries. 
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Table 1: Demographics and clinical characteristics 
 
 
No injury since  
last appointment 
N=336 (82.5%) 
Injury since 
last appointment 
N=71 (17.4%) 
P value 
Age,mean, (SD) 43.4 (16.2) 41.2 (13.3) 0.28 
Gender,female, n, (%) 196 (58.3%) 47 (66.2%) 0.22 
Duration of epilepsy, mean, 
(SD) 17.8 (14.4) 19.4 (12.4) 
0.40 
 
Presence of seizures ( ≥1 in 6 
months), n, (%) 212 (63.1%) 66 (93%) 
<0.001 
 
Presence of polytherapy,n, 
(%) 147 (43.8%) 43 (60.6%) 
0.01 
 
LAEP >45, n, (%) 92 (27.3%) 37 (52.1%) <0.001  
Depression according to 
NDDIE screening, n, (%) 70 (20) 27 (38) 0.002 
*P≤0.05 statistically significant; SD standard deviation 
	
	
	
	
	
	
	
	
 
Gur-Ozmen	et	al.,	14	
14	
	
Table 2: Severity and presence of side effects among injury (+) and injury (-) groups   
 
 
No injury since  
last appointment 
N=336 (82.5%) 
Injury since 
last appointment 
N=71 (17.4%) 
P value 
 
SE Unsteadiness, mean, (SD) 
 
2.0 (1.073) 2.45 (1.169) 0.003 
 
 
SE Tiredness, mean, (SD) 
 
 
2.87 (1.086) 3.17 (1.082) 0.014 
 
SE Restlessness, mean, (SD) 
 
1.98 (1.087) 2.46 (1.193) 0.002 
 
 
SE Agression, mean, (SD) 
 
 
1.86 (1.014) 2.00 (1.108) 0.403 
 
 
 
SE Nervousness/Agitation, mean, (SD) 
 
 
2.10 (1.097) 2.39 (1.236) 0.064 
 
 
SE Headache, mean, (SD) 
 
 
2.16 (1.072) 2.61 (1.177) 0.003 
SE Hair Loss, mean, (SD) 
 1.59 (1.061) 1.61 (1.021) 0.518 
 
 
SE Problems of Skin, mean, (SD) 
 
 
1.72 (1.056) 1.86 (0.975) 0.122 
 
 
SE Blurred Vision, mean, (SD) 
 
 
1.60 (0.944) 1.94 (1.182) 0.023 
 
SE Upset Stomach, mean, (SD) 
 
1.74 (0.983) 2.34 (1.121) <0.001 
 
SE Difficulty in Concentration, mean, 
(SD) 
 
2.16 (1.116) 2.76 (1.165) <0.001 
 
SE Trouble with Gums, mean, (SD) 
 
 
1.62 (0.964) 2.17 (1.183) <0.001 
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SE Shakey Hands, mean, (SD) 
 
 
1.87 (1.105) 2.11 (1.153) 0.079 
SE Wieght Gain, mean, (SD) 
 
 
1.84 (1.130) 1.87 (1.120) 0.666 
SE Dizziness, mean, (SD) 
  
 
1.88 (1.025) 2.52 (1.286) <0.001 
SE Sleepiness, mean, (SD) 
 
 
2.36 (1.153) 2.72 (1.173) 0.016 
SE Depression, mean, (SD) 
 
 
1.97 (1.129) 2.49 (1.252) 0.001 
SE Memory Problems, mean, (SD) 
 
 
2.45 (1.196) 2.96 (1.259) 0.001 
SE Disturbed Sleep, mean, (SD) 
 
 
 
2.31 (1.158) 2.87 (1.230) <0.001 
* p<0.0026 (Bonferroni’s correction 0.05/19); SD standard deviation 
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Table 3: Two-step cluster analysis of injury (+) group 
 
 Cluster 1 (53.5% n=38) Cluster 2 (46.5% n=33) 
LAEP >45,%,(n), (loi) 97.3% (n=37), (1) 0% (n=0), (1) 
Depression according to NDDIE 
screening, %, (n), (loi) 
65.7% (n=25), (0.43) 6.1% (n=2), (0.43)  
SE dizziness, %, (n), (loi) 50%, (n=19),  (0.39) 34% (n=11), (0.39) 
SE depression, %, (n), (loi) 55%, (n=21), (0.32) 45% (n=15), (0.32) 
SE disturbed sleep, %, (n), (loi) 73.6%, (n=28), (0.37) 55% (n=18), (0.37)  
SE difficulty in concentrating, %, (n), 
(loi) 
57.8%, (n=22), (0.30) 58% (n=19), (0.30)  
SE memory problems, %, (n), (loi) 73.6%, (n=28), (0.21) 58% (n=19), (0.21) 
SE restlesness, %, (n), (loi) 42.1%, (n=16), (0.27) 43% (n=14), (0.27) 
SE upset stomach, %, (n), (loi) 
 
 
 
Presence of seizure,%, (n), (loi) 
 
 
 
Presence of polytherapy,%, (n), (loi) 
 
44.7%, (n=17), (0.24) 
 
 
 
97.3%, (n=37), (0.06) 
 
 
 
65.7%, (n=25), (0.03) 
40% (n=13), (0.24) 
 
 
 
87.8% (n=29), (0.06) 
 
 
 
54.5% (n=18), (0.03) 
*loi level of importance 
 
